Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis

Polman CH Reingold SC Banwell B , et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011; 69(2): 292–302.

Centonze D Rossi S Tortiglione A , et al. Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery. Neurobiol Dis 2007; 27(1): 44–53.

Mori F Rossi S Piccinin S , et al. Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis. J Neurosci 2013; 33(49): 19112–19119.

Mori F Kusayanagi H Nicoletti CG , et al. Cortical plasticity predicts recovery from relapse in multiple sclerosis. Mult Scler 2014; 20(4): 451–457.

Yaka R Biegon A Grigoriadis N , et al. D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury. FASEB J 2007; 21(9): 2033–2041.

Bliss TV Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 1973; 232(2): 331–356.

Singer BH Gamelli AE Fuller CL , et al. Compensatory network changes in the dentate gyrus restore long-term potentiation following ablation of neurogenesis in young-adult mice. Proc Natl Acad Sci U S A 2011; 108(13): 5437–5442.

Zepeda A Aguilar-Arredondo A Michel G , et al. Functional recovery of the dentate gyrus after a focal lesion is accompanied by structural reorganization in the adult rat. Brain Struct Funct 2013; 218(2): 437–453.

Di Lazzaro V Profice P Pilato F , et al. Motor cortex plasticity predicts recovery in acute stroke. Cereb Cortex 2010; 20(7): 1523–1528.

Volianskis A France G Jensen MS , et al. Long-term potentiation and the role of N -methyl- d -aspartate receptors. Brain Res 2015; 1621: 5–16.

D’Aniello A Di Fiore MM Fisher GH , et al. Occurrence of D-aspartic acid and N-methyl-D-aspartic acid in rat neuroendocrine tissues and their role in the modulation of luteinizing hormone and growth hormone release. FASEB J 2000; 14(5): 699–714.

D’Aniello A D’Onofrio G Pischetola M , et al. Biological role of D-amino acid oxidase and D-aspartate oxidase. J Biol Chem 1993; 268(36): 26941–26949.

Ota N Shi T Sweedler JV. D-Aspartate acts as a signaling molecule in nervous and neuroendocrine systems. Amino Acids 2012; 43(5): 1873–1886.

Krashia P Ledonne A Nobili A , et al. Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. Neuropharmacology 2016; 103: 69–78.

Fagg GE Matus A. Selective association of N-methyl aspartate and quisqualate types of L-glutamate receptor with brain postsynaptic densities. Proc Natl Acad Sci U S A 1984; 81(21): 6876–6880.

Errico F Nisticò R Palma G , et al. Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility. Mol Cell Neurosci 2008; 37: 236–246.

Errico F Nistico R Napolitano F , et al. Increased D-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice. Neurobiol Aging 2011; 32(12): 2229–2243.

Errico F Nistico R Di Giorgio A , et al. Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals. Transl Psychiatry 2014; 4: e417.

Kujirai T Caramia MD Rothwell JC , et al. Corticocortical inhibition in human motor cortex. J Physiol 1993; 471: 501–519.

Mori F Kusayanagi H Monteleone F , et al. Short interval intracortical facilitation correlates with the degree of disability in multiple sclerosis. Brain Stimul 2013; 6(1): 67–71.

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33(11): 1444–1452.

Cutter GR Baier ML Rudick RA , et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999; 122(Pt 5): 871–882.

Krupp LB LaRocca NG Muir-Nash J , et al. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123.

Sharples SA Gould JA Vandenberk MS , et al. Cortical mechanisms of central fatigue and sense of effort. PLoS ONE 2016; 11(2): e0149026.

Axell A-M MacLean HE Plant DR , et al. Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. Am J Physiol Endocrinol Metab 2006; 291(3): E506–E516.

Roshanzamir F Safavi SM. The putative effects of D-Aspartic acid on blood testosterone levels: A systematic review. Int J Reprod Biomed (Yazd) 2017; 15(1): 1–10.

Yu G Traish AM. Induced testosterone deficiency: from clinical presentation of fatigue, erectile dysfunction and muscle atrophy to insulin resistance and diabetes. Horm Mol Biol Clin Investig 2011; 8(1): 425–430.

D’Aniello S Somorjai I Garcia-Fernàndez J , et al. D-Aspartic acid is a novel endogenous neurotransmitter. FASEB J 2011; 25(3): 1014–1027.

Brown ER Piscopo S Chun J-T , et al. Modulation of an AMPA-like glutamate receptor (SqGluR) gating by L- and D-aspartic acids. Amino Acids 2007; 32(1): 53–57.

Errico F Rossi S Napolitano F , et al. D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801. J Neurosci 2008; 28(41): 10404–10414.

Topo E Soricelli A Di Maio A , et al. Evidence for the involvement of D-aspartic acid in learning and memory of rat. Amino Acids 2010; 38(5): 1561–1569.

D’Aniello A Lee JM Petrucelli L , et al. Regional decreases of free D-aspartate levels in Alzheimer’s disease. Neurosci Lett 1998; 250(2): 131–134.

Kim PM Duan X Huang AS , et al. Aspartate racemase, generating neuronal D-aspartate, regulates adult neurogenesis. Proc Natl Acad Sci U S A 2010; 107(7): 3175–3179.

Kojovic M Bologna M Kassavetis P , et al. Functional reorganization of sensorimotor cortex in early Parkinson disease. Neurology 2012; 78(18): 1441–1448.